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SUMMARY
Many viruses shut off host gene expression to inhibit antiviral responses. Viral proteins and host 
proteins required for viral replication are typically spared in this process, but the mechanisms of 
target selectivity during host shutoff remain poorly understood. Using transcriptome-wide and 
targeted reporter experiments, we demonstrate that the influenza A virus endoribonuclease PA-X 
usurps RNA splicing to selectively target host RNAs for destruction. Proximity-labeling 
proteomics reveals that PA-X interacts with cellular RNA processing proteins, some of which are 
partially required for host shutoff. Thus, PA-X taps into host nuclear pre-mRNA processing 
mechanisms to destroy nascent mRNAs shortly after their synthesis. This mechanism sets PA-X 
apart from other viral host shutoff proteins that target actively translating mRNAs in the 
cytoplasm. Our study reveals a unique mechanism of host shutoff that helps us understand how 
influenza viruses suppress host gene expression.
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In Brief
Gaucherand et al. uncover a unique relationship between RNA degradation by the influenza A 
virus ribonuclease PA-X and host RNA splicing, which allows PA-X to selectively target host 
RNAs for destruction.
Graphical Abstract
INTRODUCTION
Despite their small genomes, influenza A viruses (IAVs) dedicate multiple proteins to the 
suppression of host gene expression, or “host shutoff,” which limits host antiviral responses. 
One of these IAV host shutoff proteins is the endoribonuclease PA-X, which selectively 
degrades host RNAs (Jagger et al., 2012; Khaperskyy et al., 2016) and limits innate immune 
responses in vivo. PA-X-deficient viruses induce stronger innate immune and inflammatory 
responses in mice, chickens, and pigs (Gao et al., 2015; Gong et al., 2017; Hayashi et al., 
2015; Hu et al., 2015, 2016; Jagger et al., 2012; Xu et al., 2017). In some IAV strains, the 
immune-evasion activity of PA-X reduces inflammation-induced pathology, thereby 
protecting the host and reducing mortality (Gao et al., 2015; Gong et al., 2017; Hu et al., 
2015, 2016; Jagger et al., 2012). While the role of PA-X in immune evasion is well 
established, its molecular mechanism of action remains poorly understood.
PA-X is produced by ribosomal frameshifting during the translation of the polymerase acidic 
protein (PA) mRNA (Firth et al., 2012; Jagger et al., 2012). The frameshift generates a 
protein with the PA amino-terminal ribonuclease (RNase) domain fused to a unique 
carboxy-terminal domain known as the X-open reading frame (X-ORF). The X-ORF is 
required for PA-X function (Hayashi et al., 2016; Khaperskyy et al., 2016; Oishi et al., 
2015). Despite this non-canonical production mechanism, PA-X is en-coded by all IAV 
strains (Shi et al., 2012). We previously reported that PA-X selectively degrades RNAs 
transcribed by host RNA polymerase II (Pol II), but not other polymerases (Khaperskyy et 
al., 2016). This characteristic leads to the protection of viral RNAs created by the viral 
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RNA-dependent RNA polymerase (RdRp) (Khaperskyy et al., 2016). However, the 
mechanism for PA-X targeting of Pol II transcripts is not known.
Other viruses encode host shutoff RNases that selectively target Pol II transcripts, including 
alphaherpesviral vhs proteins, gammaherpesviral SOX/BGLF5 proteins, and the severe acute 
respiratory syndrome-related coronavirus (SARS-CoV) non-structural protein 1 (nsp1) 
(Covarrubias et al., 2009, 2011; Elgadi et al., 1999; Gaglia et al., 2012; Glaunsinger and 
Ganem, 2004a; Kamitani et al., 2006; Rowe et al., 2007). However, SARS nsp1 and the 
herpesviral host shutoff proteins operate in the cytoplasm and only degrade transcripts that 
are bound by components of the protein synthesis machinery (Covarrubias et al., 2011; 
Doepker et al., 2004; Feng et al., 2001, 2005; Gaglia et al., 2012; Kamitani et al., 2009). By 
contrast, PA-X accumulates in the nucleus, and the protein synthesis machinery has no role 
in RNA targeting and degradation (Hayashi et al., 2016; Khaperskyy et al., 2016). Our 
previous analysis of select transcripts suggests that not all Pol II transcripts are equally 
susceptible to PA-X degradation (Khaperskyy et al., 2016), similar to reports for other viral 
host shutoff RNases (Esclatine et al., 2004; Glaunsinger and Ganem, 2004b). In agreement 
with this, a recent study of the host transcriptome in IAV-infected cells showed that certain 
functional classes of RNAs were spared from shutoff, although no specific link to PA-X 
activity was established (Bercovich-Kinori et al., 2016). By contrast, in the context of 
studying the relative contribution of IAV PA-X and NS1 proteins to host shutoff, Toru 
Takimoto’s group recently reported that host mRNAs targeted by PA-X do not clearly 
belong to specific functional classes, whereas there is functional specificity among NS1 
targets (Chaimayo et al., 2018). These findings suggest that PA-X may have a unique 
mechanism to selectively target host RNAs in the nucleus, perhaps in conjunction with RNA 
processing and the assembly of functional messenger ribonucleoprotein (mRNP) complexes.
Here, we report transcriptome-wide analysis of PA-X targets in human lung A549 cells, in 
both de novo infection and ectopic expression models. This analysis revealed that PA-X 
susceptibility is tightly linked to Pol II transcript splicing. Moreover, we identified host 
proteins involved in mRNA processing that associate with the C-terminal X-ORF, suggesting 
that PA-X target selection may involve physical interactions with components of the host 
mRNA processing machinery.
RESULTS
PA-X Causes Global Changes in RNA Levels during Infection
To determine the scope of PA-X specificity for host Pol II transcripts, we profiled RNA 
levels in cells infected with wild-type (WT) and PA-X-deficient IAVs. To generate PA-X-
deficient mutants in the well-characterized strain A/PuertoRico/8/1934 H1N1 (PR8), we 
introduced 2 mutations in the frameshifting site and a nonsense mutation in PA-X, 
L201Stop, that truncated the X-ORF after 9 amino acids (aa); we called this virus PA(ΔX) 
(Figure 1A). These mutations were designed to be silent in the PA ORF. We previously used 
a strain with only the frameshifting mutations, IAV PA(fs) (Figure S1A) (Khaperskyy et al., 
2016), but we created IAV PA(ΔX) to ensure that any residual frameshifting would produce 
a non-functional PA-X. We confirmed that the 9-aa truncated PR8 PA-X was largely 
inactive, as it lost the ability to degrade a β-globin reporter, whereas an X-ORF truncation to 
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15 aa retained activity (Figure 1B). The β-globin reporter includes the two introns of the 
native β-globin gene, and expresses an mRNA that is spliced. The results in Figure 1B 
recapitulate previous findings using truncations in PA-X variants from other strains (Hayashi 
et al., 2016; Oishi et al., 2015). We also generated a virus with only the L201Stop mutation 
and called it “X9” (Figure S1A). We chose to use the PR8 strain because it lacks two other 
known IAV host shutoff mechanisms; its NS1 protein does not block host mRNA processing 
(Das et al., 2008; Salvatore et al., 2002), and its RdRp does not trigger Pol II degradation 
(Rodriguez et al., 2009).
Using high-throughput RNA sequencing (RNA-seq), we found that the infection of cells 
with WT IAV caused a dramatic global decrease in transcript levels compared to mock-
infected cells (Figure 1C; Data S1). However, a small fraction of transcripts escaped shutoff 
(right tail end of distribution; Figure 1C). By contrast, shutoff was substantially attenuated in 
IAV PA(ΔX)-infected cells. Cells infected with strains carrying either the PA(X9) or PA(fs) 
mutations also displayed attenuated host shutoff, and the defect was similar in all three 
mutants (Figure S1B). This demonstrates that X-ORF truncation disrupts PA-X function 
during infection, as predicted from ectopic PA-X expression studies (Hayashi et al., 2016; 
Khaperskyy et al., 2016; Oishi et al., 2015). Infection rates by WT and mutant viruses were 
comparable, based on immunofluorescence staining and viral protein levels (Figures S2A 
and S2B). We also measured the nuclear accumulation of cytoplasmic poly(A) binding 
protein (PABP), a well-described consequence of host shutoff (Khaperskyy et al., 2014; 
Kumar and Glaunsinger, 2010; Kumar et al., 2011; Lee and Glaunsinger, 2009). Infection 
with PA(X9) and PA(ΔX) viruses resulted in significantly lower rates of PABP nuclear 
accumulation compared to WT, confirming the impairment of host shutoff (Figures S2A and 
S2C). Lastly, our RNA-seq results strongly correlated with those from a previous 
transcriptome profile of IAV PR8-infected cells (Bercovich-Kinori et al., 2016), despite the 
differences in multiplicity of infection (MOI) and time course of analysis (Figure 1D). These 
data demonstrate that PA-X controls the levels of the majority of host RNAs during 
infection.
PA-X Causes Global Downregulation of Host RNAs in an Ectopic Expression Model
To simplify our system, we also examined changes in RNA levels after ectopic PA-X 
expression. We used a doxycycline-inducible PA-X expression system, “iPA-X” cells 
(Khaperskyy et al., 2016), to induce the expression of WT PA-X or the catalytically inactive 
D108A mutant in A549 cells. Because iPA-X cells were clonally selected, we analyzed 2 
independently generated cell lines for each variant. As expected from previous results with 
targeted RT-qPCR and metabolic labeling (Hayashi et al., 2015; Jagger et al., 2012; 
Khaperskyy et al., 2016), WT PA-X robustly downregulated steady-state transcript levels 
(Figure 2A; Data S2). The degree of host shutoff correlated with the levels of PA-X 
(percentage of total reads mapping to PA-X: WT #1 = 0.005%–0.006%, WT #10 = 0.023%–
0.026%) and was dependent on RNase activity, because expression of the PA-X catalytic 
mutant had no effect (Figure 2A). A substantial minority of transcripts was unaffected by 
PA-X expression (right tail end of distributions; Figure 2A). Furthermore, we observed a 
highly significant correlation between the PA-X-dependent downregulation of RNAs in the 
ectopic PA-X expression system and in virus-infected cells (Figure 2B). This indicates that 
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PA-X largely targets the same RNAs in the absence of other viral proteins and that the 
ectopic expression model accurately reflects the contribution of PA-X to host shutoff during 
infection. To further validate these findings, we selected representative RNAs, choosing 
RNAs that were strongly downregulated (glyceraldehyde-3-phosphate dehydrogenase 
[GAPDH], glucose-6-phosphate dehydrogenase [G6PD]) or largely unaffected 
(heterogeneous nuclear ribonucleoprotein A0 [HNRNPA0], TATA-box binding protein 
associated factor 7 [TAF7], enhancer of polycomb homolog 1 [EPC1]) in both de novo 
infection and ectopic expression models. We then validated the change in RNA levels in 
iPA-X cells by RT-qPCR. The RT-qPCR results agreed with the RNA-seq data in terms of 
the selective effects on the tested transcripts (Figure 2C). By contrast, doxycyline-inducible 
expression of the catalytically inactive PR8 PA-X D108A mutant or the PA-X RNase 
domain (aa 1–191, “N term”) did not affect the level of any of the tested transcripts (Figure 
2C). Expression of PA-X or the RNase domain was confirmed by western blotting (Figure 
2D). Because the RNase domain alone is active in vitro (Bavagnoli et al., 2015; Dias et al., 
2009; Yuan et al., 2009), this result confirms that it is specifically the activity of PA-X and 
not the overexpression of any active RNase that controls RNA levels in the iPA-X cells. 
Moreover, the mRNA levels were similarly affected by the expression of PA-X from the A/
Udorn/72 H3N2 (Udorn) strain, suggesting that target selection by PA-X is conserved 
among virus strains (Figure 2C). These data demonstrate that PA-X broadly targets RNA for 
degradation, while a subset of RNAs remains unaffected.
Specific Functional Classes of Host RNAs Are Differentially Sensitive to PA-X
Although most RNAs were downregulated by PA-X, the levels of ~25% of RNAs remained 
largely unchanged (Figures 1C and 2A). To identify resistant RNAs, we used k-means 
clustering to group RNAs with similar patterns of regulation (Gasch and Eisen, 2002). 
Clustering was carried out based on the relative RNA levels in PA-X-overexpressing (OE) 
cells versus control cells or IAV-versus mock-infected cells in our 8 datasets (Figures 1C, 
2A, and S1B). Two sets of RNAs making up 55% of the RNAs that were detected in all 
conditions were identified as true PA-X targets (Figure 3A; Data S1a and S2a). These RNAs 
were downregulated in a PA-X-dependent manner both during infection and by PA-X 
ectopic expression. The RNAs in the first set were completely PA-X-specific, as their levels 
were largely unchanged in IAV PA(ΔX)-infected cells (Figure 3A, left). The RNAs in the 
second set were PA-X sensitive, but were partially downregulated by other mechanisms 
during IAV PA(ΔX) infection (Figure 3A, right). By contrast, 28% of the RNAs were PA-X 
resistant and were not downregulated by infection or PA-X expression (Figure 3B; Data S1b 
and S2b). In addition, the k-means algorithm identified a group of RNAs that were 
downregulated during infection by a PA-X-independent mechanism and yet were PA-X 
sensitive in PA-X-expressing cells (Figure 3C; Data S1c and S2c). The levels of these 
transcripts may be substantially decreased by other regulatory mechanisms during infection, 
such that their targeting by PA-X is masked. Based on Gene Ontology (GO) term analysis, 
the host shutoff-resistant RNAs were significantly enriched for genes involved in 
transcription and translation, including ribosomal RNA processing, ribosomal proteins, and 
membrane protein synthesis (Figure 3D). This result is consistent with the IAV requirement 
for host biosynthetic machinery and observations by Bercovich-Kinori et al. (2016). These 
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results suggest that while PA-X can target many RNAs, it retains some specificity for 
functional classes of RNAs.
In addition to this unbiased analysis, we examined how PA-X expression affected the levels 
of interferon-stimulated genes (ISGs), which are induced in infected cells and function in 
antiviral defense (Schoggins et al., 2011). We observed that although ISGs were induced 
during IAV infection, as shown by their higher expression compared to all of the detected 
RNAs, their levels were even higher in the absence of PA-X (Figure 3E). While the activity 
of PA-X is clearly not limited to ISGs, these data indicate that PA-X can contribute to 
dampening the cell-intrinsic response to infection.
PA-X Strongly and Preferentially Downregulates Spliced Pol II Transcripts
We previously showed that PA-X selectively degrades RNA transcribed by Pol II and spares 
Pol I and Pol III transcripts (Khaperskyy et al., 2016). Although all cellular transcripts are 
modified post-synthesis, only Pol II transcripts can be spliced. The process of RNA splicing 
is mechanistically linked to transcription, as recruitment of the spliceosome is mediated by 
the C-terminal domain of the large subunit of Pol II (Gu et al., 2013). However, a subset of 
Pol II transcripts naturally lacks introns. When we analyzed spliced versus intronless RNAs 
separately, we found that PA-X downregulated spliced RNAs more than intronless RNAs 
(Figure 4A). Our targeted validation also showed that two intronless mRNAs, TAF7 and 
HNRNPA0, were not downregulated by PA-X (Figure 2C), and, as mentioned above, the β-
globin reporter used in Figure 1B encodes a spliced mRNA. Moreover, during infection, the 
downregulation of spliced RNAs was clearly dependent on PA-X, whereas most of the 
downregulation of intronless RNAs was PA-X independent (Figure 4B). For these analyses, 
we only included intronless RNAs longer than 300 nt, excluding small non-coding RNAs 
and ensuring that the length distribution was similar between spliced and intronless RNAs. 
We also analyzed how the number of exons affected RNA downregulation, as the number of 
splice sites varies dramatically among spliced RNAs. There was a significant negative 
correlation between the number of exons in a transcript and its steady-state levels in PA-X-
expressing and infected cells (PA-X-expressing cells: Spearman’s ρ = −0.52, Figure 4C; 
IAV-infected cells: Spearman’s ρ = −0.47, Figure S3A). This result suggests that RNAs with 
more exons are more susceptible to PA-X degradation. However, the number of exons in an 
RNA is often proportional to RNA length. A prior study reported a relation between IAV 
host shutoff and transcript length (Bercovich-Kinori et al., 2016). Likewise, there was a 
correlation between degradation and RNA length in our data (Spearman’s ρ = −0.38 for 
both PA-X-expressing [Figure 4D] and IAV-infected cells [Figure S3B]). To determine 
whether exon number or transcript length was important, we examined RNAs of similar 
length or with a specific number of exons. We still found a robust negative correlation 
between relative RNA levels in the presence of PA-X and exon number among RNAs of 
similar length (length = 3.5–4.0 kb, Spearman’s ρ = −0.42, N = 674; Figure 4E). Similar 
correlations were also seen for RNAs of other lengths (Figure S3C). By contrast, there was 
only a small correlation between degradation and RNA length among RNAs with the same 
number of exons (number of exons = 6, Spearman’s ρ = −0.16, N = 642; Figure 4F). Again, 
similar correlations were seen for other exon numbers (Figure S3D). We also tested another 
Gaucherand et al. Page 6
Cell Rep. Author manuscript; available in PMC 2019 May 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
key characteristic of RNAs, guanine-cytosine (GC) content, and found no correlation with 
PA-X activity in our dataset (Figures S3E and S3F).
The results from the clustering and GO analyses (Figures 3A–3D) suggest that PA-X 
differentially regulates RNAs from specific functional groups, whereas Figures 4A–4F 
suggest a difference based on the structure of the nascent transcript. Inter-estingly, we found 
a connection between the structural and functional specificity. RNAs classified as resistant 
by k-means clustering (shown in Figure 3B) had fewer exons than those classified as PA-X 
targets (shown in Figure 3A) (Figure 4G). These results suggest that targeting by PA-X is 
connected to RNA splicing and that this preference has consequences for the selection of 
functionally relevant targets.
Splice Sites Confer Susceptibility to PA-X
Endogenous RNAs with different numbers of exons also have different sequences, lengths, 
and post-transcriptional modifications. To investigate the effect of splicing in a more 
controlled system, we examined the same RNA in both spliced and intronless forms. We 
used interferon λ2 (IFN-λ2) mRNA as a model transcript. IFN-λ2 is a type III IFN that 
contributes to IAV immune responses (Jewell et al., 2010). In the RNA-seq, IFN-λ2 
transcripts were detectable only in IAV-infected cells and were downregulated by PA-X 
(Figure S4A). We cloned the IFN-λ2 cDNA and the full IFN-λ2 genomic sequence 
containing introns into plasmid expression vectors (Figure 5A) and co-transfected them into 
HEK293T cells with PR8 PA-X. In these transfection experiments, the detection of PA-X 
protein is hindered by auto-cleavage of the PA-X Pol II transcript. As an alternative control 
to ensure comparable PA-X activity between transfections, we also measured the RNA levels 
of a co-transfected intron-containing luciferase reporter (Younis et al., 2010); luciferase 
downregulation thus serves as a positive control for PA-X activity (Figures 5B–5D, and 5G). 
We confirmed that IFN-λ2 mRNA was expressed and exported to the cytoplasm at similar 
levels, irrespective of the construct used (Figures S4B and S4C). We also checked that the 5 
introns were properly spliced by PCR analysis (Figures 5E, 5F, and S4D). As expected, we 
found that PA-X downregulated the IFN-λ2 mRNA expressed from the full genomic region 
(Figure 5B). However, the levels of the same IFN-λ2 mRNA expressed from an intronless 
cDNA construct were only minimally reduced (Figure 5B). In both conditions, the control 
luciferase reporter was downregulated by PA-X, confirming that the activity of PA-X was 
similar in all of the samples. PA-X proteins from the 2009 pandemic H1N1 strains (e.g., A/
California/7/09H1N1 [CA/7] and A/Tennessee/1–560/2009) and the Udorn H3N2 strain also 
preferentially degraded the spliced mRNAs (Figure 5C). These results confirm the 
prediction that splicing is important for PA-X targeting. In addition, we tested the 
downregulation of IFN-λ2 mRNAs expressed from chimeric constructs that contained only 
1 of the 5 introns from the original genomic sequence to determine whether a single splicing 
event was sufficient to restore PA-X targeting. Addition of a single intron increased 
susceptibility to PA-X (Figure 5D). Downregulation of the luciferase reporter indicated that 
these changes were not due to varying PA-X activity in the samples. We found that while the 
addition of introns 1, 3, or 5 alone restored PA-X susceptibility, introns 2 or 4 had little 
effect. The difference between the introns was also apparent when we normalized IFN-λ2 to 
luciferase mRNA levels (Figure S4E). Intron 4 was not spliced efficiently in the absence of 
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other introns (Figure 5E), but intron 2 was still efficiently spliced (Figure 5F). Therefore, 
splicing efficiency alone does not explain the differential effects of the introns. More in-
depth examination of the IFN-λ2 sequence revealed that the 5′ splice sites for introns 1, 3, 
and 5 match the consensus 5′ splice site sequence, AG|GT (where | marks the splice site). 
By contrast, the 5′ splice sites for introns 2 and 4 are an imperfect match (TA | GT and GT | 
GT, respectively). 5′ splice-site quality scores calculated using the MaxEntScan::score5ss 
program were also higher for introns 1, 3, and 5 (8.8–10.5) than introns 2 and 4 (5.8) (Yeo 
and Burge, 2004). When we mutated these two 5′ splice sites to match the consensus 
sequence AG|GT and increase the splice site quality score (mutated introns 2 and 4 = 10.7), 
we found that the mutated introns 2 and 4 could restore PA-X susceptibility (Figures 5G and 
S4F normalized to luciferase mRNA levels) and intron 4 splicing efficiency (Figure 5E). 
This result further strengthens the link between splicing and PA-X susceptibility.
Despite these results linking mRNA splicing and PA-X degradation, one unresolved issue is 
that we and others have previously used intronless reporters to study PA-X, and they 
appeared to be efficiently degraded. To investigate this issue, we compared intronless and 
spliced luciferase reporters (Younis et al., 2010). The spliced reporter, which we used as a 
control in Figures 5B–5G, contains a portion of the β-globin intron (Younis et al., 2010). 
PA-X had a more robust effect on the spliced mRNA, although it could also downregulate 
intronless luciferase mRNA (Figures 5H and S4G). These results suggest that the addition of 
a single splicing event further promotes degradation by PA-X. Reporter constructs are 
selected for their robust expression; it is possible that certain intronless reporters also 
associate with cellular factors involved in PA-X targeting. Never-theless, our findings lead us 
to recommend the use of intron-containing reporters for future cell-based studies of PA-X.
The X-ORF Mediates Interaction with Proteins Involved in RNA Metabolism
As shown in previous studies (Hayashi et al., 2016; Khaperskyy et al., 2016; Oishi et al., 
2015) and the PR8 PA(X9) RNA-seq results (Figure S1B), the C-terminal X-ORF is 
required for PA-X activity. We hypothesized that the X-ORF interacts with cellular proteins 
that mediate the association of PA-X with target mRNAs, especially in light of our results 
connecting PA-X targeting with splicing (Figures 4 and 5) and mRNA 3′ end processing 
(Khaperskyy et al., 2016). To identify cellular X-ORF-interacting proteins, we used BioID, a 
proteomic technique that relies on non-specific proximity biotinylation of lysine residues by 
a modified Escherichia coli biotin ligase, BirA* (Roux et al., 2012). Since there are two 
major classes of PA-X isoforms that differ in X-ORF length (Shi et al., 2012), we fused 
BirA* to X-ORFs representative of each class: the 61-aa PR8 X-ORF (X61) and the 41-aa 
CA/7 X-ORF (X41) (Figure 6A). We used BirA* alone and BirA* fused to a mutated PR8 
X-ORF in which 4 positively charged residues were replaced by alanine (X61(4A)) as 
negative controls. These mutations prevent the nuclear localization of a GFP-X-ORF fusion 
and disrupt mRNA degradation by PA-X (Khaperskyy et al., 2016). As expected from our 
previous studies (Khaperskyy et al., 2016), fusion to the WT X-ORFs, but not X61(4A), led 
to the accumulation of BirA* in the nucleus (Figure S5A). Moreover, all BirA* fusions 
efficiently biotinylated many cellular proteins (Figure S5B).
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To identify cellular proteins that bind both the X61 and X41 X-ORFs, we affinity-purified 
biotinylated proteins from HEK293T cells expressing BirA*-X-ORF fusion proteins and 
prepared them for quantitative mass spectrometry using reductive dimethylation. Reductive 
dimethylation exploits formaldehyde variants with different molecular weights due to 
substituted carbon-13 or deuterium atoms to label captured proteins with stable isotope tags 
and allow quantitative comparisons among samples (Hsu et al., 2003). We performed the 
experiment 3 times—twice with BirA*-X61 and once with BirA*-X41—comparing them in 
each case to the BirA* alone and BirA*-X61(4A) controls (Figure 6A). A total of 156 
candidate X-ORF-interacting proteins were represented by at least 2 unique peptides (Table 
S4) and were present in all of the runs (Figure 6B). Among these, we selected 29 high-
confidence interacting proteins with higher relative peptide abundance in the test (BirA*-
X61 or -X41) versus control (BirA*-X61(4A) or BirA* alone) conditions (>2-fold higher 
than controls in at least 2 experiments or >1.5-fold in all 3 experiments; Figure 6D; Table 
S4). Figure 6C depicts the relative peptide abundance of proteins in X61 samples compared 
to the X61(4A) control or the BirA* alone control, with black and red open circles 
identifying the high-confidence hits. Red circles indicate 2 proteins (nucleolin [NCL], 
nucleophosmin [NPM1]) that were enriched >2-fold compared to controls across all 3 runs. 
Because NCL and NPM1 are abundant proteins that traffic in and out of nucleoli, these 
interactions may explain the apparent nucleolar accumulation of biotinylated proteins 
(Figures S5A and S5C), even though neither the BirA-X-ORF fusion (Figure S5A) nor the 
full-length PA-X (Khaperskyy et al., 2014, 2016) accumulate in nucleoli. A STRING 
protein-protein interaction network analysis of the hits revealed several physical and 
functional interaction nodes, including protein trafficking, transcription, translation, and 
mRNA processing (Figure 6D). Similarly, GO term analysis revealed a strong association 
with mRNA processing, RNA splicing, and mRNA metabolic process functions among the 
high-confidence hits (Figure 6E). These data show that the PA-X C-terminal X-ORF is 
physically recruited to protein complexes involved in nuclear Pol II RNA processing 
(commonly referred to as mRNA processing), which likely explains the preferential 
degradation of RNAs that have undergone co- or post-transcriptional processing.
The CFIm Complex May Regulate PA-X Activity
The BioID screen identified several proteins involved in RNA splicing (RNA binding motif 
protein 39 [RBM39], poly(U) binding splicing factor 60 [PUF60], and pre-mRNA 
processing factor 4 [PRPF4]) and/or polyadenylation (nudix hydrolase 21 [NUDT21]/
cleavage and polyadenylation specificity factor 5 [CPSF5]/cleavage factor Im 25 [CFIm25] 
and CPSF6/CFIm68) as X-ORF-interacting proteins. We conducted co-immunoprecipitation 
experiments to validate these interactions using nuclear extracts derived from an HEK293T 
iPA-X cell line that produces high levels of a myc-tagged PA-X (Khaperskyy et al., 2016). 
We recapitulated the interaction between full-length PA-X and endogenous NUDT21, 
suggesting that this is a stable interaction that can survive affinity isolation procedures 
(Figures 7A and S6A). NUDT21 and CPSF6 assemble into a functional heterotetrameric 
CFIm complex (Kim et al., 2010) that enhances polyadenylation and guides polyadenylation 
site choice (Zhu et al., 2018). In addition, the CFIm complex is present in the spliceosome 
and has been proposed to link splicing to polyadenylation during RNA processing 
(Rappsilber et al., 2002; Zhou et al., 2002). To test whether the interaction with the CFIm 
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complex was required for PA-X activity, we used small interfering RNAs (siRNAs) to 
deplete NUDT21 and CPSF6 alone or in combination (Figures S6B and S6F). Partial 
silencing of CFIm proteins reduced PA-X downregulation of IFN-λ2 upon co-transfection in 
HEK293T cells (Figure 7B). Moreover, in A549 cells, silencing of the CFIm complex 
reduced PABP nuclear localization during IAV PR8 infection (Figures 7C and 7E), a 
hallmark of PA-X dependent host shutoff (Figure S2; Khaperskyy et al., 2014). PABP 
relocalization was quantified on a per-cell basis to control for unrelated effects of the 
knockdowns on cell viability and infection rates. In fact, we found that NUDT21 silencing 
reduced cell viability, and CPSF6 silencing dramatically reduced infection rates (Figure 7D). 
We also tested two additional potential interaction partners, NCL and RBM39, in the PABP 
relocalization assay (Figures S6C and S6E). While NCL silencing had little effect on cell 
viability, infection rates, and host shutoff, RBM39 silencing reduced cell viability and 
infection rates (Figures S6C–S6F). We conclude that NCL is unlikely to have a role in PA-
X-mediated host shutoff, whereas the effects of RBM39 silencing on cell physiology are too 
severe to assess its role in PA-X host shutoff. Nonetheless, these data suggest that the RNA 
processing and spliceosome-associated CFIm complex is required for at least some of the 
activity of PA-X in cells.
DISCUSSION
A thorough understanding of the molecular mechanism of action of PA-X is required to 
determine how it selectively degrades host RNAs and limits innate immune response. In this 
study, we discovered a key aspect of the PA-X mechanism of action: its selectivity for 
transcripts that are spliced. This coupling to RNA processing sets PA-X apart from other 
viral host shutoff RNases that target mRNAs in the cytoplasm in association with translation 
(Covarrubias et al., 2009; Doepker et al., 2004; Feng et al., 2001, 2005; Gaglia et al., 2012; 
Kamitani et al., 2009). Our transcriptomic results show that, as expected, PA-X 
downregulates many host RNAs, both on its own and in the context of infection. However, 
some RNAs are less susceptible to PA-X activity, and a key characteristic of these resistant 
RNAs is that they are intronless or have fewer introns. Moreover, the C-terminal X-ORF of 
PA-X interacts with many proteins involved in cellular RNA metabolism. We propose a 
model whereby PA-X associates with a discrete set of RNA metabolism proteins that allows 
selective targeting of RNAs during transcription or early processing. In this model, RNAs 
that are not canonically processed, including viral RNAs, are spared.
Our transcriptomic study confirms that the PA-X-dependent downregulation of host protein 
production (Hayashi et al., 2015; Jagger et al., 2012) is due to a reduction in RNA levels, 
and defines PA-X-dependent and PA-X-independent components of RNA downregulation 
during infection. The PA-X-independent component is likely due to a recently described 
generalized reduction in cellular transcription (Bauer et al., 2018; Heinz et al., 2018; Zhao et 
al., 2018), because other known modalities of IAV host shutoff are not active in the PR8 
strain (Das et al., 2008; Rodriguez et al., 2009; Salvatore et al., 2002). The mechanism of 
reduced host transcription in IAV-infected cells remains a matter of debate (Bauer et al., 
2018; Heinz et al., 2018; Zhao et al., 2018). However, it is most likely PA-X independent, 
because transcription is also reduced during infection with influenza B viruses (Bauer et al., 
2018), which do not encode PA-X (Shi et al., 2012). Our clustering analysis also revealed 
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that some functional classes of RNAs are spared from PA-X degradation, including mRNAs 
for proteins involved in translation, which agrees with previous results from Bercovich-
Kinori et al. (2016) (Figure 3D). Our new results suggest that the small number of exons of 
these mRNAs, particularly RNAs for ribosomal proteins, may explain this phenomenon.
Another general conclusion of our RNA-seq analysis is that PA-X with a 9-aa truncated C-
terminal X-ORF is essentially non-functional in the context of infection. The shutoff 
impairment of IAV PA(X9) is very similar to that of the PA(fs) and PA(ΔX) viruses (Figure 
S1B), which presumably have reduced PA-X production. This finding validates the results of 
multiple studies using ectopic PA-X expression models that concluded that at least 15 aa of 
the X-ORF is required for full RNA degrading activity in cells (Hayashi et al., 2016; 
Khaperskyy et al., 2016; Oishi et al., 2015), despite in vitro activity of the RNase domain in 
isolation (Bavagnoli et al., 2015; Dias et al., 2009; Yuan et al., 2009). Similarly, a 1918 
H1N1 chimeric virus with a stop codon after 15 aa had an intermediate host shutoff 
phenotype between IAV WT and PA(fs) (Jagger et al., 2012). The finding that truncating the 
X-ORF is sufficient to block PA-X activity in the virus is important because single-point 
mutations in the X-ORF sequence are less disruptive than frameshifting mutations. Thus, 
viruses carrying X-ORF mutations could be better tools for in vivo studies of PA-X function 
and IAV pathogenesis.
The key unexpected finding from our study is the link between PA-X and splicing. All other 
viral host shutoff RNases appear to act at some stage of mRNP loading into the translation 
apparatus. For example, RNA targeting by the alphaherpesvirus protein vhs is linked to 
physical interactions with translation initiation factors (Doepker et al., 2004; Feng et al., 
2001, 2005) and SARS CoV nsp1 only degrades RNAs that are actively translated (Gaglia et 
al., 2012; Kamitani et al., 2009). Thus, to our knowledge, there is no other described 
instance of a host shutoff RNase using splicing as a targeting mechanism. In fact, splicing 
was reported to protect mRNAs from cleavage by vhs (Sadek and Read, 2016). The 
connection between splicing and PA-X degradation is evident from the reduced effect of PA-
X on intronless mRNAs (Figures 4 and 5), the negative correlation between exon number 
and degree of degradation by PA-X (Figures 4 and S3), and the fact that small changes in the 
5′ splice site can affect the susceptibility to degradation by PA-X (Figures 5G and S4F). 
These findings begin to shed light on the specificity of PA-X for Pol II transcripts 
(Khaperskyy et al., 2016). In cellular transcription, the splicing machinery associates with 
RNAs through interactions with Pol II, and thus only Pol II transcripts are normally spliced 
(Gu et al., 2013). Protein-protein interactions with splicing factors may thus bring PA-X to 
its Pol II targets. This idea is corroborated by our proteomic analysis, which shows that the 
PA-X X-ORF interacts with several splicing regulators (PUF60, RBM39, PRPF4) and 
spliceosome-associated polyadenylation proteins (the CFIm complex proteins NUDT21 and 
CPSF6) (Figure 6). Furthermore, PA-X activity is in part dependent on the CFIm complex 
(Figure 7). We speculate that more exons provide more chances for PA-X to be brought to 
the RNA by these factors, resulting into more efficient turnover of RNAs with more splice 
sites. Since these proteins do not regulate the processing of all of the mRNAs in the cell to 
the same extent, PA-X interactions with these proteins could provide an additional 
mechanism for target discrimination. Further studies will be needed to determine the exact 
role of these factors.
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A targeting strategy based on splicing offers a major benefit to the virus because it provides 
the ability to easily discriminate between host and viral mRNAs. Viral mRNAs are 
synthesized by the RdRp, and most of them are not spliced, which renders them “invisible” 
to PA-X. That said, our published results suggest that even the two viral mRNAs that are 
spliced (nuclear export protein [NEP] and matrix protein 2 [M2]) are PA-X resistant 
(Khaperskyy et al., 2016). However, splicing of viral mRNAs is a fundamentally different 
process, since the splicing machinery needs to be recruited to the RNAs separately from Pol 
II (Dubois et al., 2014). It is possible that viral mRNA splicing does not require the CFIm 
complex or other PA-X-binding partners, because they are auxiliary components of the host 
RNA processing machinery. The PA-X splicing-based targeting strategy is more efficient at 
virus versus host discrimination than the translation-based targeting strategy used by 
herpesviral host shutoff RNases, which leads to the degradation of viral and host mRNAs 
alike (Abernathy et al., 2014). This is likely because viral translation relies on the same 
machinery as host translation. While herpesviruses can compensate for the degradation of 
their own RNAs, this self-sacrifice may not work for a virus such as IAV, which has a shorter 
replication cycle and a small genome with a limited gene expression program.
Our BioID results suggest that the preference for spliced RNAs may be linked to protein-
protein interactions between the PA-X X-ORF and cellular factors. The X-ORF is required 
for PA-X nuclear localization (Hayashi et al., 2016; Khaperskyy et al., 2016; Oishi et al., 
2015). However, enforced nuclear localization of the PA-X RNase domain alone does not 
fully rescue activity (Hayashi et al., 2016), suggesting that the X-ORF has additional 
functions. We identified many X-ORF-interacting proteins with various roles in RNA 
metabolism in addition to a nuclear import protein (import in 7 [IPO7]). By examining the 
X-ORF in isolation, we likely excluded indirect interactions via RNA binding of the RNase 
domain, as well as interactions that are important for PA rather than PA-X function. Among 
our hits, two nucleolar proteins, NCL and NPM1, were also reported to interact with H5N1 
PA-X (Li et al., 2016). The fact that biotinylated proteins accumulated in the nucleoli also 
supports the idea that NCL and NPM1, which traffic to nucleoli, come in contact with the 
BirA*-fused X-ORF and full-length PA-X (Figure S5C). It is unclear whether PA-X 
interaction with nucleolar proteins is of functional importance, since silencing NCL had 
little effect on PA-X-mediated host shutoff in infected cells (Figures S6C–S6F) and PA-X is 
not localized specifically to this compartment (Figure S5A; Khaperskyy et al., 2014, 2016). 
NCL has been reported to protect specific RNAs from degradation by viral host shutoff 
RNases, including PA-X (Muller and Glaunsinger, 2017; Muller et al., 2015). Therefore, the 
PA-X-NCL interaction may reflect a different role for NCL in regulating RNA homeostasis 
during infection. By contrast, we found evidence for the involvement of the CFIm complex 
(NUDT21 and CPSF6) in host shutoff during infection (Figures 7D and 7E) and PA-X 
ectopic expression (Figure 7B). The findings in infected cells must be interpreted with 
caution because CPSF6 silencing markedly inhibited viral infection (Figures 7D, 7F, and 
S6F). It is unclear whether the reduction in infection rates is connected to PA-X function. 
While the CFIm complex is more commonly studied for its roles in alternative 
polyadenylation and mRNA 3′ processing (Hardy and Norbury, 2016), multiple studies have 
shown that NUDT21 and CPSF6 are found in purified spliceosome complexes (Rappsilber et 
al., 2002; Zhou et al., 2002). This finding has led to the idea that they may also play a role in 
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the coordination of splicing and 3′ processing (Martinson, 2011). In a previous study, we 
reported that canonical 3′ end processing may also be linked to PA-X targeting (Khaperskyy 
et al., 2016); the CFIm complex may also explain this connection. Little is known about the 
function of the CFIm complex, so studying its contribution to PA-X activity and/or IAV 
infection may advance the understanding of its normal physiological role. Roles for the other 
candidate PA-X-interacting proteins remain to be explored; such studies may be hindered if 
these proteins play PA-X-independent roles in the viral replication cycle or in maintaining 
general cell viability during infection. For example, we found that silencing RBM39, an 
alternative splicing regulator, had profound negative effects on cell survival and infection 
rates (Figures S6D–S6F). We also wonder whether the association of PA-X with cellular 
proteins could compromise their normal function. We did not find dramatic changes in host 
splicing in our dataset (not shown), but others have reported increased intron retention in 
cells infected with a PR8 chimeric virus bearing a 1918 NS1 protein (Zhao et al., 2018). 
This discrepancy could be due to the way we set up our sequencing pipeline or to the NS1 
variant present in the virus. Because these changes were attributed to NS1 activity, we must 
be cautious in our assessment of PA-X-dependent and PA-X-independent effects in our 
system.
It is interesting that both PA-X and the well-known influenza host shutoff factor NS1 
interact with nuclear mRNA processing machinery to control gene expression (Nemeroff et 
al., 1998). Many NS1 variants (but not PR8 NS1) cause host shutoff by binding and 
inhibiting a component of the 3′ end RNA processing machinery, CPSF30 (Das et al., 2008; 
Nemeroff et al., 1998). While this convergence could allow the two proteins to coordinate an 
attack on the host, studies of engineered and naturally evolved viruses suggest that NS1 and 
PA-X activities are anti-correlated to prevent cytotoxicity. For example, the original 2009 
pandemic H1N1 NS1 does not bind CPSF30, nor does it reduce host gene expression (Hale 
et al., 2010), but the more human-adapted NS1 from currently circulating pandemic H1N1 
strains does (Clark et al., 2017; Nogales et al., 2018). These H1N1 strains have also 
accumulated mutations that reduce PA-X activity, suggesting that having two highly active 
host shutoff proteins may impair viral fitness (Nogales et al., 2018). A recent study by the 
Takimoto lab comparing NS1 and PA-X targeting in a 2009 pandemic strain suggests that 
NS1 and PA-X have overlapping but not identical targets (Chaimayo et al., 2018). NS1 is 
more clearly directed at downregulation of the innate immune response, whereas PA-X has a 
broader targeting range (Chaimayo et al., 2018). In general, host mRNA processing may be 
a hub of regulation for influenza because viral mRNAs are generally not processed by host 
machinery. Also, interactions with host mRNA processing do not directly compromise Pol II 
activity, which is required for viral replication (Lamb and Choppin, 1977).
Our results affirm the importance of PA-X for the viral replication cycle, as they show that 
the ability of the virus to regulate host gene expression is severely reduced in the absence of 
PA-X. Moreover, we have uncovered a unique mechanism of host RNA targeting that can 
allow PA-X to distinguish not only between host and viral targets but also among cellular 
targets. For example, the intronless mRNA TAF7, which we examined in Figures 2B and 2C, 
is a component of Pol II pre-initiation complexes. Therefore, PA-X selectivity could have 
repercussions for the viral replication cycle. Through further elucidation of the PA-X 
mechanism of action, we will gain important insights into how host shutoff allows the virus 
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to usurp host biosynthetic machinery and expand our knowledge of the link between PA-X 
and IAV pathogenesis.
STAR★METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and request for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Marta M. Gaglia (Marta.Gaglia@tufts.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines—Human embryonic kidney cells HEK293A (Thermo Fisher) and HEK293T 
(ATCC), and human adenocarcinoma alveolar basal epithelial (A549, ATCC) cells were 
obtained from commercial sources. HEK293A and HEK293T are female and A549 are 
male. All cell lines and derivatives were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum (Hyclone) at 37°C and 5% CO2. 
HEK293T_iPA-X-PR8, A549-iPA-X_PR8 and A549-iPA-X-D108A_PR8 were previously 
described (Khaperskyy et al., 2016). A549-iPA-X_Udorn and iPA-X_PR8_Nterm were 
generated by transducing A549 cells with lentiviruses containing pTRIPZ-PA-X_Udorn-myc 
and pTRIPZ-PA-X_PR8-Nterm-myc.
METHOD DETAILS
Plasmids—pCR3.1-PA-X-myc (with PR8 PA-X) (Khaperskyy et al., 2014), pCR3.1-PA-
N191 (PA-X 0 aa) (Khaperskyy et al., 2016), pCR3.1- PA-X_TN/CA/7-myc (Khaperskyy et 
al., 2016), pd2GFP-HR (Lee and Glaunsinger, 2009), pCDNA3.1-β-globin ((Covarrubias et 
al., 2011), subcloned from the pcTet2-bwt plasmid (Singh et al., 2008)) were previously 
described. The luciferase constructs with and without the intron were a kind gift from 
Gideon Dreyfuss (Younis et al., 2010). pHW-PA(X9) and pHW-PA(ΔX) were generated 
from pHW-193 (kind gift from R. Webby) and pHW-PA(fs) vectors (Khaperskyy et al., 
2016), respectively, using Phusion site-directed PCR mutagenesis to introduce the TAG stop 
codon in +1 ORF (synonymous ATT to ATA substitution at PA Ile-201 codon, TTG to TAG 
substitution at PA-X Leu-201). pCR3.1-PA-X_9aa-myc and pCR3.1-PA-X_15aa-myc were 
generated from the pCR3.1-PA-X-myc constructs by amplifying the truncated coding region 
and inserting it into the SalI-MluI sites of a pCR3.1-C-terminal-myc backbone. pCR3.1-PA-
X_Udorn-myc was generated by PCR amplifying the 5′ portion of the segment 3 RNA from 
a PolI-Udorn construct (kind gift from A. Mehle), adding a single nucleotide deletion to 
shift the frame of the X-ORF, and inserting into the SalI-MluI sites of a pCR3.1-C-terminal-
myc backbone. pTRIPZ-PA-X-Nterm-myc and pTRIPZ_PA-X_Udorn-myc were generated 
by PCR amplifying PA-N191 from pCR3.1-PA-N191-myc and PA-X-Udorn-myc from 
pCR3.1-PA-X_Udorn-myc, respectively, and inserting these sequences into the backbone of 
pTRIPZ-RFP_SV40_3′UTR (Khaperskyy et al., 2016) after RFP excision with AgeI and 
ClaI. pCMV-IFN-λ2 cDNA, genomic and single intron constructs were generated by PCR 
amplifying the full human IFN-λ2 cDNA, the genomic locus, or combinations of fragments 
of the two, and inserting into the pd2eGFP-N1 construct (Clontech) after the GFP was 
excised using NheI and NotI. The 5′ splice site of intron 2 or 4 was then mutated from TTA|
GT and TGT|GT, respectively, to CAG|GT within the single-intron constructs to generate the 
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intron 2 and 4 mutant constructs. Gibson cloning using HiFi assembly mix (New England 
Biolabs) was used to make all of these constructs, unless otherwise stated. The expression 
vector for the biotin ligase from E. coli with the R118G mutation BirA* (pcDNA3.1-myc-
BioID2-MCS) (Roux et al., 2012) was obtained from Addgene (#74223) and the BirA* ORF 
was amplified by PCR and inserted into the pCR3.1-myc vector (Khaperskyy et al., 2012) 
between KpnI and EcoRI sites to generate pCR3.1-BirA*-myc. The PCR-amplified X-ORF 
sequences from pCR3.1-PA-X-myc and pCR3.1-PA-X(4A)-myc (Khaperskyy et al., 2016) 
were inserted in frame with BirA* ORF using EcoRI and MluI to generate pCR3.1- BirA*-
X61-myc and pCR3.1-BirA*-X61(4A)-myc, respectively. X-ORF coding sequence from A/
California/7/2009 H1N1 strain was amplified from pHW-C3 vector (Slaine et al., 2018) and 
inserted in frame with BirA* ORF using EcoRI and XhoI to generate pCR3.1-BirA*-
X41(CA/7) vector.
Cell lines, lentiviral transduction and transfections—HEK293A, HEK293T, A549 
cells and derivatives were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (Hyclone) at 37°C and 5% CO2. 
HEK293T_iPA-X-PR8, A549-iPA-X_PR8 and A549-iPA-X-D108A_PR8 were previously 
described (Khaperskyy et al., 2016). A549-iPA-X_Udorn and iPA-X_PR8_Nterm were 
generated by transducing A549 cells (ATCC) with lentiviruses containing pTRIPZ-PA-
X_Udorn-myc and pTRIPZ-PA-X_PR8-Nterm-myc. Lentiviral packaging was carried out 
using the packaging plasmids psPAX2 and pMD2.G (Addgene #12260, #12259). For 
experiments using iPA-X cells, cells were treated with 0.2 mg/ml doxycycline for 18 h to 
induce PA-X expression prior to RNA or protein sample collection. For the RNaseq 
experiments, untransduced A549 cells were also treated with doxycycline to serve as the 
control. For experiments using IFN-λ2 constructs and the β-globin reporter, HEK293T cells 
were plated in 24-well or 6-well plates (for fractionation experiments) and transfected with 
800 ng/ml total DNA (including 50 ng/ml PA-X construct) using polyethylenimine (PEI). 
Cells were collected 24 h later for fractionation and/or RNA extraction and purification, and 
cell lysates for western blot. For siRNA transfections, HEK293T cells were plated in 6-well 
plates while transfecting 15 nM siRNA (ThermoFisher Scientific) per well using 
Lipofectamine RNAiMAX reagents (ThermoFisher Scientific). Cells were transfected two 
days later with 800 ng/ml total DNA (including 50 ng/ml PA-X construct) using PEI, and 
collected for RNA and protein 24 h later.
Viruses and infections—Wild-type influenza A virus A/Puerto Rico/8/1934 H1N1 
(PR8) and the mutant recombinant viruses PR8 PA(X9), PR8 PA(fs) and PR8 PA(ΔX) were 
generated using the 8-plasmid reverse genetic system (Hoffmann et al., 2000) as previously 
described (Khaperskyy et al., 2012). Viral stocks were produced in MDCK cells and 
infectious titers determined by plaque assays in MDCK cells using1.2% Avicel overlays as 
described in Matrosovich et al. (Matrosovich et al., 2006). A549 cell monolayers were 
mock-infected or infected with the wild-type or mutant viruses at MOI = 1 for 1 h at 37°C. 
Then monolayers were washed briefly with PBS, fresh infection media (0.5% BSA in 
DMEM supplemented with 20 μM L-glutamine) was added and cells incubated at 37°C in 
5% CO2 atmosphere for 12 or 15 h prior to RNA isolation or preparation of lysates for 
western blotting. For immunofluorescence microscopy analysis cells grown on glass 
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coverslips were infected as described above and fixed at 15 h post-infection using 4% 
paraformaldehyde in PBS.
Preparation of cell lysates containing biotinylated proteins—HEK293T cells 
grown on 10-cm dishes were washed briefly and transfected with BirA* fusion protein 
expression constructs using PEI. At 6 h post transfection, media was changed to 10% FBS 
DMEM supplemented with 50 μM biotin (Sigma). 24 h post-transfection (18 h post-biotin 
addition) cells were washed and collected in ice cold PBS, and centrifuged at 250 × g for 5 
min at 4°C. Cell pellets were resuspended in 500 μl RIPA buffer (50 mM Tris-HCl pH 7.4, 
150 mM NaCl, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS) with protease inhibitor 
cocktail (P8340, Sigma) and lysed at 4°C for 1 h with gentle agitation, followed by passing 
through a 21-gauge needle. Lysates were cleared by centrifugation at 4°C for 20 min at 
20,000 × g.
Neutravidin pull-down—60 ml of 50% slurry of High Capacity Neutravidin Agarose 
Beads (Thermo) was used for each 500 μl of clarified whole cell lysate. Beads were 
equilibrated in RIPA buffer by washing three times for 10 min at 4°C. In one of the BirA*-
X61 experimental runs, 1 μl of 500x RNase A (100 mg, QIAGEN) was added to each 
sample to remove non-specific interactors. The lysate was then incubated for 5 min at room 
temperature before loading onto the beads. Untreated samples were loaded directly onto the 
beads post washing. 1 mg of protein sample was loaded to beads in 1.5 ml Eppendorf tubes, 
which were then placed on a rotator overnight at 4°C, and collected with centrifugation at 
400 × g for 1 min at 4°C. Beads were washed with RIPA buffer three times, followed by 
three washes with TAP buffer (50 mM HEPES-KOH pH 8.0, 100 mM KCl and 10% 
glycerol).
Mass spectrometry sample preparation—Beads were resuspended in 50 mM 
triethylammonium bicarbonate (TEAB) buffer (Sigma). 24 mM DTT and 32 mM IAcNH2 
were added sequentially. Beads were then incubated for 30 min at 37°C, washed with 50 
mM TEAB and centrifuged for 1 min at 400 × g before resuspending in 50 mM TEAB. On-
bead trypsin (Pierce Trypsin protease, MS-Grade; Thermo Scientific) digest was performed 
with 1 μg trypsin in 50 mM TEAB buffer, shaken overnight at 37°C. Samples were acidified 
with 1 μl trifluoroacetic acid (TFA) and 3 μl Formic acid until a pH lower than 3 was 
achieved. Trypsinized peptides were collected by puncturing a hole in the bottom of the 1.5 
ml Eppendorf tube using a 30-gauge needle, placing it in a 2 ml Eppendorf tube and 
spinning it at 2000 rpm for 1 min at room temperature. Beads were washed with 50 mM 
TEAB prior to desalting. Samples were desalted with Oasis/SepPak Desalting columns, 
eluted sequentially in 1 ml 50% ACN/0.1% TFA and 500 μl 70% ACN/0.1% TFA. 
Combined eluted samples were dried in a Thermo SPDIIIV speed vacuum centrifuge and 
frozen at −20°C.
Reductive dimethylation and quantitative mass spectrometry—Quantitative mass 
spectrometry analysis via reductive dimethylation enabled measurements of relative 
abundance of biotinylated proteins in each experimental condition (Hsu et al., 2003). In 
reductive dimethylation, formaldehyde molecules with different combinations of stable 
Gaucherand et al. Page 16
Cell Rep. Author manuscript; available in PMC 2019 May 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hydrogen and carbon isotopes are conjugated to peptide samples. Dried protein samples 
were resuspended by sonication for 15 min in 50 mM TEAB. BirA*, BirA*-XORF (X61 or 
X41) and BirA*-X61(4A) samples were labeled with light, medium and heavy isotopes 
respectively. 8 μl formaldehyde (Sigma) were added to the light, 15 μl D2-formaldehyde 
(Cambridge Isotope Laboratories Inc.) to the medium and 15 μl D2-C13-formaldehyde 
(Aldrich) to the heavy samples. Reactions were incubated for 5 min at room temperature. 
Once incubation was completed, 0.51 M NaCNBH3 (sodium cyanoborohydride; Fluka) was 
added to the light and medium samples, while 0.51 M NaCNBD3 (sodium 
cyanoborodeuteride; Aldrich) was added to the heavy reaction, to label terminal amines. All 
three reactions were incubated for 1 h at room temperature before being combined into a 
single tube at a 1:1:1 ratio. The combined sample was acidified, desalted and dried as 
described above. Samples were resuspended in 3% ACN/0.1% formic acid and sonicated for 
15 min to prepare for mass spectrometry. Mass spectrometry and peptide identification was 
performed at Dalhousie Proteomics CORE Facility by Dr. Alejandro Cohen (https://
medicine.dal.ca/research/mass-spectrometry-proteomics-and-metabolomics.html). Proteome 
Discoverer software (Thermo) was used for protein identification. Functional Protein 
Association Network analysis was conducted on 29 selected protein hits using online 
STRING version 10.5 (https://string-db.org/) (Szklarczyk et al., 2017).
Cell fractionation for RNA analysis—Fractionation was performed as described 
previously (Gagnon et al., 2014) with minor modifications. Briefly, cells were collected 24 h 
after transfection, centrifuged at 500 × g for 5 min at 4°C, then washed with PBS and 
counted. Equal numbers of cells were aliquoted into two tubes, one for the whole cell lysates 
collection and one for fractionation. Cells were pelleted again, and lysed on ice for 10 min in 
250 μl ice-cold hypotonic lysis buffer (10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl2, 
0.3% (vol/vol) NP-40, 10% (vol/vol) glycerol in nuclease-free water) supplemented with 
100 U RNasin (Promega). For the whole cell lysate, Trizol (Life Technologies) was added 
directly to the lysate to extract RNA. For nuclear/cytoplasmic fraction, the lysate was 
centrifugated at 1000 × g for 3 min at 4°C to pellet membrane and nuclei. The supernatant 
was collected as the cytoplasmic fraction and Trizol was added to it to extract RNA. Finally, 
the nuclear pellet was washed 3 times with 1 ml hypotonic lysis buffer and collected by 
centrifugation at 200 × g for 2 min at 4°C, then lysed directly in Trizol to extract nuclear 
RNA.
RNA purification, cDNA preparation and qPCR—For fractionation experiments, 
RNA was purified using Trizol. 1 ml Trizol, 2 μl glycogen and 200 μl chloroform (Fisher 
Scientific) were added to each fraction. Samples were then centrifuged at 16,000 × g for 15 
min at 4°C, and the aqueous layer was collected. RNA was precipitated by addition of 700 μl 
isopropanol and incubation for 10 min at room temperature, followed by centrifugation at 
16,000 × g, 4°C for 20 min. The pellet was washed with 75% ethanol, and resuspended in 
RNase-free water. For other transfection experiments, RNA was extracted from cells and 
purified using the Quick-RNA miniprep kit (Zymo Research), following manufacturer’s 
protocol. In all cases, the RNA was treated with Turbo DNase (Life Technologies), then 
reverse transcribed using iScript supermix (Bio-Rad) per manufacturer’s protocol. In the 
fractionation experiment, the same cell equivalents of total, nuclear and cytoplasmic fraction 
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were used for these steps. qPCR was performed using iTaq Universal SYBR Green supermix 
(Bio-Rad), on the Bio-Rad CFX Connect Real-Time System qPCR and analyzed with Bio-
Rad CFX Manager 3.1 program. The primers used are listed below.
Intron splicing verification—Proper splicing of each intron for all IFN-λ2 construct was 
verified by PCR amplification across each splice sites using primers listed below. PCR 
products were run on a 2% agarose gel containing HydraGreen safe DNA dye (ACTGene) 
and imaged with a Syngene G:Box Chemi XT4 gel doc system.
Co-immunoprecipitation from nuclear lysates—HEK293T_iPA-X-PR8 cells were 
plated in 10-cm dishes. Cells were then treated with 1 μg/ml doxycycline for 18 h to induce 
PA-X expression. Fractionation of nuclear lysates was performed as described previously 
(Dadi et al., 2013) with minor modifications. Briefly, cells were washed with ice-cold 
Dulbecco’s PBS and centrifuged at 1,200 rpm for 6 min at 4°C to collect the cells. Cell 
pellets were lysed in 50 μl of a sucrose-based lysis buffer (0.32 M sucrose, 3 mM CaCl2, 2 
mM MgOAc, 0.1 mM EDTA, 10 mM DTT, 0.5 mM PMSF). An additional 50 ml of sucrose 
lysis buffer with 0.5% (vol/vol) NP40 was added to the lysate. The lysate was centrifuged 
for 10 min at 1,100 × g at 4°C. The supernatant was collected as the cytoplasmic fraction, 
whereas the pellet was washed in 100 μl of sucrose lysis buffer, and centrifuged for 10 min 
at 2,000 rpm at 4°C. The supernatant was discarded and the pellet was lysed in 100 μl of 
Soluble Nuclear Lysis Buffer (50 mM HEPES pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM 
EDTA, 10% Glycerol, 1 mM DTT, 0.1 mM PMSF, cØmplete protease inhibitors (Roche)) 
and incubated on a rotating rotor at 4°C for 45 min. Samples were centrifuged at 10,000 × g 
for 3 min at 4°C. 20 μl of the supernatant was collected as the input sample, and the rest was 
added to myc-trap magnetic agarose beads (ChromoTek), or control magnetic agarose beads 
(ChromoTek) and incubated on a rotating rotor for 45 min at 4°C. Beads were collected on a 
magnetic rack and washed 6 times with wash buffer (50 mM Tris HCl pH 7.4, 150 mM 
NaCl, 1 mM EDTA, 0.05% NP40, cØmplete protease inhibitors (Roche)). 25 μl of Laemmli 
sample buffer was added to the beads, and samples were incubated for 10 min at 95°C prior 
to SDS-PAGE and western blotting.
Western blotting and immunofluorescence—Western blotting and 
immunofluorescence were carried out as previously described (Khaperskyy et al., 2014, 
2016) using the antibodies listed in the Key Resources Table. For detection of biotinylated 
proteins, HRP-conjugated streptavidin (Cell Signaling) and Alexa Fluor-488-conjugated 
streptavidin (Molecular Probes) were used.
RNA-seq—For RNA-seq analysis of PA-X-expressing cells, A549 and A549 iPA-X cells 
were induced with 0.2 μg/ml doxycycline for 18 h. For RNA-seq analysis of infected cells, 
A549 cells were infected with PR8 wt, PA(fs), PA(X9), and PA(ΔX) viruses or mock 
infected for 15 h. Each condition was tested at least twice. RNA lysates were collected and 
purified using the RNeasy kit (QIAGEN). 650–750 ng of RNA were mixed with ERCC 
ExFold RNA spike-in mix (0.65 μl or 0.75 μl, respectively, Invitrogen/ThermoFisher) prior 
to the start of library preparation. The spike-in controls were included to better normalize the 
final RNA levels. This particular kit contains two mixes that can be used for the control 
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versus test samples and that have known fold change differences. This information can be 
used to re-calibrate the samples. Prior to library preparation, the levels of select human 
mRNAs were tested by RT-qPCR, to confirm that PA-X overexpression/IAV infection had 
the expected effect. Libraries were prepared using the TruSeq Stranded Total RNA Library 
Prep Kit with Ribo-Zero Human (Illumina) following the manufacturer’s protocol. Library 
preparation was evaluated using a Fragment Analyzer (Advanced Analytical Technologies, 
Inc.) at the Tufts University Core Facility - Genomics Core. High-throughput sequencing 
was carried out by the Tufts Genomics facility on a HiSeq 2500. Single-end 50 nucleotide 
reads were obtained with a multiplexing strategies, using a total of four lanes. For the 
replicates, the spike mixes for the samples and the barcoded primers were switched, in order 
to control for potential biases.
Read alignment and bioinformatic analysis—Reads were aligned with Tophat2 
v2.1.1 (Kim et al., 2013) to hg19, IAV PR8 and the ERCC spike sequences. Default settings 
were used, except --library-type fr-firststrand, and a gtf of the hg19 annotation was provided 
as reference. Table S1 summarizes the results of the alignment. FPKMs were computed 
using Cufflinks v2.2.1 (Trapnell et al., 2012). Default settings were used, except --library-
type fr-firststrand and –u, and a gtf of the hg19 annotation was provided as reference. Only 
previously annotated RNAs with a level of >1 FPKM in all the control samples (A549 + dox 
or mock-infected A549) were used in further analyses. Because most annotated RNAs are 
Pol II transcripts, the downstream analysis includes predominantly Pol II transcripts. The 
FPKMs for the RNAs were converted to attomoles of RNA based on the known 
concentration of the spike-in controls. Table S2 shows the high correlation in measured RNA 
levels between replicate samples. The absolute RNA levels in the replicates were averaged, 
and the relative RNA levels (RNA ratio) in infected versus mock infected or PA-X-
expressing versus control cells was computed. All downstream analysis was carried out on 
the relative levels (ratio) in log2 scale. Data S1 and S2 include tables that summarize the 
results of the RNaseq analyses. The hg19 annotation was used to derive the number of 
exons, length of transcripts and GC content for the analyses in Figures 4, S3. For analysis of 
intronless RNAs, only RNAs that were longer than 300 nt were used, to enrich for mRNAs 
and long non-coding RNAs and exclude small non-coding RNAs that are transcribed by Pol 
III or are produced through processing of longer transcripts, like microRNAs and small 
nuclear and nucleolar RNAs. The length distribution of the remaining intronless RNAs was 
similar to that of the spliced RNAs. All RNAs were used for the analysis of PA-X 
downregulation versus length, exon number, and GC content. k-means clustering analysis 
was carried out using the Cluster 3.0 program (http://bonsai.hgc.jp/~mdehoon/software/
cluster/software.htm). The clustering was done only on RNAs that were detected in all 
samples tested (6,391 RNAs), because all eight datasets were used to generate the clusters, 
even though only the mRNA levels for select samples are plotted in Figures 3A–C for 
clarity. The classified RNAs listed in Data S1a, S1b, S1c and S2a, S2b, S2c represent these 
6,391 RNAs. Because in k-means clustering the number of clusters is user-defined, 
clustering was attempted with three, four, and five clusters. Four clusters were chosen, 
because they provided more granularity. For example, they identified a group of RNAs that 
were only PA-X-dependent in the ectopic expression system. Initializing the program with 
more than four clusters led to separation of PA-X targets in multiple groups different only by 
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the extent of downregulation, but did not identify other patterns of gene expression. Gene 
ontology (GO) term analysis was carried out on the DAVID server (Huang et al., 2009a, 
2009b). The 5′ splice site quality score was computed using the MaxEntScan::score5ss 
program using the maximum entropy model (Yeo and Burge, 2004). Other analyses were 
done using custom scripts in Python2.7. For the ISG analysis (Figure 3E) the list of ISG 
tested by Schoggins et al. was used (Schoggins et al., 2011).
QUANTIFICATION AND STATISTICAL ANALYSIS
For Figures 1B, 2C, 5, 7, S4, S6, statistical analysis and plotting were done in GraphPad 
Prism v7.0d software using the test recommended by the software and indicated in the figure 
legends. Generally, ANOVA followed by a corrected pairwise test (Tukey’s or Dunnett’s) 
was used when more than two samples were analyzed and Student’s t test when two samples 
were compared. For Figures 1C and 1D, 2A and 2B, 4, statistical analysis and plotting were 
done using Python2.7 and the NumPy, SciPy and matplotlib libraries. The Kolmogorov-
Smirnoff test was used to compare populations and Spearman’s correlation coefficient to 
analyze the relationship between certain variables and RNA downregulation. Statistical tests 
used for each panel are noted in Figure legends and/or Figures.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE120183 
(raw read data and processed data included here as Data S1 and S2).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Influenza A virus PA-X targets the majority of host mRNAs for destruction
• Downregulation by PA-X correlates with the number of splice sites in a 
transcript
• Splicing renders RNAs susceptible to PA-X
• The cellular CFIm complex interacts with PA-X and contributes to PA-X 
activity
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Figure 1. PA-X Downregulates Most Cellular RNAs and Is a Major Contributor to Host Shutoff 
during Influenza A Virus Infection
(A) Diagram of mutations in the PR8 PA(ΔX) virus. Less intense colors indicate lower levels 
of PA-X. Blue, position of the frameshift. Red, mutated nucleotides in the frameshifting 
sequence and at PA-X codon 201.
(B) HEK293T cells were transfected for 24 h with a β-globin reporter and WT PR8 PA-X 
(“61”) or variants with the C-terminal X-ORF truncated after the indicated number of amino 
acids (aa). Levels of β-globin in PA-X transfected cells were measured by RT-qPCR and are 
plotted relative to vector transfected cells, after normalization to cellular 18S rRNA. Values 
represent means ± SDs. n = 3. *p < 0.05, and **p< 0.01, ANOVA followed by Dunnett’s 
multiple comparison test versus WT PA-X (61 aa).
(C) RNA-seq was carried out on RNA collected 15 h after infection from A549 cells 
infected with WT PR8 or PR8 PA(ΔX). The ratio between levels in IAV-infected versus 
mock-infected cells was computed for each RNA and the distribution of the ratios (log2) is 
plotted as a frequency histogram. The populations are significantly different (p < 0.001) 
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based on the Kolmogorov-Smirnoff test. The dashed line indicated a ratio of 1 (no change). 
n ≥ 2.
(D) The ratio in RNA levels in WT IAV-infected cells versus mock-infected cells in our 
study (15 h post-infection, MOI = 1) is plotted against the results from Bercovich-Kinori et 
al. (2016) (8 h post-infection, MOI = 5). p < 0.001, Spearman’s test.
See also Figures S1 and S2.
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Figure 2. PA-X Downregulates Most Cellular RNAs in the Absence of Other Viral Proteins
RNA and protein samples were collected from control (untransduced) A549 cells or A549 
cells expressing doxycycline-inducible PR8 PA-X (WT), PR8 PA-X catalytic mutant 
(D108A), PR8 PA-X N-terminal endonuclease domain (aa 1–191, “N term”), or Udorn PA-
X 18 h after the addition of doxycycline.
(A) RNA-seq was carried out on cells expressing WT or mutant PR8 PA-X (2 clonal lines 
for each). The ratio between the levels in PA-X-expressing versus control cells was 
computed for each RNA, and the distribution of the ratios is plotted as a frequency 
histogram. The dashed line indicates a ratio of 1 (no change). n ≥ 2.
(B) The PA-X-dependent changes in RNA levels in infected cells (ratio in PR8 PA(ΔX) 
versus WT PR8) are plotted against changes in cells expressing PR8 PA-X versus control 
cells. p < 0.001, Spearman’s test.
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(C) Levels of several endogenous mRNAs were measured by RT-qPCR in cells expressing 
the indicated PA-X variants. After normalization to 18S, mRNA levels are plotted relative to 
uninduced cells. Values represent means ± SDs. n ≥ 3. **p < 0.01 and ***p < 0.001. 
ANOVA followed by Dunnett’s multiple comparison test versus PR8 PA-X D108A.
(D) A representative western blot using anti-myc antibodies to detect myc-tagged PA-X and 
a total protein stain as loading control (blot section from 25 to 35 kDa) shows successful 
induction of PA-X in each cell line (corresponds to one of the experiments shown in C).
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Figure 3. k-Means Clustering Reveals Differentially Regulated Groups of RNAs
(A–C) Cluster 3 was used to divide cellular RNAs in 4 clusters based on the pattern of fold 
changes in iPA-X cells (PA-X WT or D108A catalytic mutant versus control) and cells 
infected with IAV (WT or PA-X-deficient IAV versus mock). Cumulative probability 
histograms of fold changes for each of the classes are plotted: (A) 2 groups of PA-X targets, 
(B) PA-X-resistant RNAs, (C) potential PA-X targets that are regulated by other processes 
during infection. All of the datasets collected were used for clustering, but only select 
datasets are plotted for simplicity.
(D) DAVID was used to identify overrepresented Gene Ontology (GO) terms for biological 
processes and molecular functions among PA-X-resistant RNAs. Fold enrichment is plotted 
for GO terms that had corrected p < 0.01.
(E) Pie charts showing the percentage of genes that are up- and downregulated in infected 
and iPA-X cells. Left: all RNAs detected in RNA-seq (WT versus mock: N = 8,573, PR8 
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PA(ΔX) versus mock: N = 8,848, PA-X overexpression (OE) versus control: N = 8,554). 
Right: interferon-stimulated genes (ISGs; WT versus mock: N = 167, PR8 PA(ΔX) versus 
mock: N = 168, PA-X OE versus control: N = 159).
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Figure 4. RNAs that Are Not Spliced Are Less Sensitive to Regulation by PA-X
(A and B) RNA-seq results from Figures 1C and 2A are plotted separately for spliced and 
intronless RNA as cumulative distribution histograms. (A) Cells overexpressing WT PA-X, 
clones #1 and #10; (B) cells infected with WT PR8 versus PR8 PA(ΔX).
(C–F) Relative RNA levels in PA-X overexpressing (OE; clone #1) versus control cells are 
plotted against the number of exons (C and E, log2 scale) or transcript length in kilobases (D 
and F, log10 scale). (C and D) All RNAs, (E) RNAs with 6 exons, and (F) RNAs 3.5–4.0 kb 
in length. All of the correlations are statistically significant (p < 0.001, Spearman’s test).
(G) The number of exons for RNAs identified in the clustering analysis (Figure 3) is plotted. 
The two groups of PA-X targets (Figure 3A) are plotted together. p < 0.01, Kolmogorov-
Smirnoff test.
See also Figure S3.
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Figure 5. Addition of Introns and Splicing Events Promotes Degradation by PA-X
(A) Diagram of IFN-λ2 constructs. Int, intron.
(B–G) HEK293T cells were transfected for 24 h, with reporters expressing a luciferase 
control mRNA and IFN-λ2 mRNA from cDNA, the genomic locus, cDNA with 1 of the 5 
IFN-λ2 introns added back, or cDNA with IFN-λ2 introns 2 or 4 carrying mutations that 
restore a canonical 5′ splice site sequence. Cells were also transfected with PA-X (PR8 
variant in B, D, and G; PR8, CA/7, and Udorn variants in C) or vector. Levels of luciferase 
and IFN-λ2 mRNAs were measured by RT-qPCR and plotted as relative levels in PA-X 
expressing versus vector-transfected cells, after normalization to 18S rRNA. The 
downregulation of a spliced luciferase mRNA serves as a control to ensure similar PA-X 
activity across samples. In (E) and (F), cDNA from vector-transfected cells was PCR 
amplified across the indicated introns to test splicing. Amplified PCR products are shown 
(image is representative of 4 experiments). A 1:1 mix of the IFN-λ2 cDNA and genomic 
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constructs was included to check that unspliced and spliced products could be 
simultaneously amplified.
(H) Cells were transfected with an intronless (−) or an intron-containing (+ intron) luciferase 
reporter and PR8 PA-X. Luciferase RNA levels were measured by RT-qPCR, normalized by 
18S rRNA, and were plotted relative to vector-transfected cells.
Values represent means ± SDs; n ≥ 4. *p < 0.05, **p < 0.01; For (B) and (C), ANOVA 
followed by Tukey’s pairwise test; (D) ANOVA followed by Dunnett’s test, p values relative 
to cDNA construct; (H) Student’s t test. See also Figure S4.
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Figure 6. The X-ORF Interactome Is Enriched for Proteins Involved in mRNA Processing
(A) Schematic diagram of X-ORF-BirA* fusion baits used in the BioID mass spectrometry 
experiment. The numbers indicate independent runs using each construct set. Light, 
medium, and heavy = light, medium, or heavy isotope tags.
(B) Overlap between proteins identified by mass spectrometry by ≥2 unique peptides in 3 
BioID runs.
(C) Average relative abundance of 286 proteins identified in at least 2 BioID experiments, 
plotted as log2 ratio of medium versus light (x axis, X-ORF/−) and medium versus heavy (y 
axis, X-ORF/X61(4A)). Green dots represent proteins with >1.5-fold enrichment over both 
negative controls; blue dots represent proteins with >1.5-fold enrichment over BirA*-myc 
alone; black and red open circles represent high-confidence hits (>2.0-fold over BirA*-myc 
in ≥2 experiments or >1.5-fold over BirA*-myc and BirA*-X61(4A)-myc in 3 experiments); 
red open circles represent nucleolin (NCL) and nucleophosmin (NPM1), which were 
enriched >2.0-fold over both negative controls in all 3 experiments.
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(D) STRING protein-protein interaction network of high-confidence hits. Apparent nodes 
were differentially colored (only 1 annotation per protein is shown for simplicity).
(E) Gene Ontology (GO) enrichment analysis of X-ORF BioID hits (black and red circles in 
C). All enriched functional classes are presented (excluding parental subclasses for each 
term). Note that the >100-fold enriched functional classes contain only 2 proteins each.
See also Figure S5.
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Figure 7. The CFIm Complex Is Involved in PA-X Activity
(A) Proteins were extracted from the nuclei of uninduced or doxycycline-treated HEK293T 
cells expressing inducible WT PR8 PA-X, and incubated with myc-trap beads to 
immunoprecipitate PA-X-myc (myc) or control beads (ctrl). Input and immunoprecipitation 
(IP) samples were resolved by SDS-PAGE and analyzed by western blotting for PA-X-myc, 
NUDT21, and CPSF6. The image is representative of 3 independent experiments.
(B) NUDT21 and CPSF6 were knocked down by siRNA, separately or in combination, in 
HEK293T cells. For NUDT21, siRNA #2 was used (see STAR Methods). For CPSF6, 
siRNA #1 was used for knockdown in combination with NUDT21. Cells were then 
transfected with a reporter expressing IFN-λ2 mRNA from the genomic locus, with and 
without WT PR8 PA-X. The levels of IFN-λ2 mRNA and 18S rRNA were measured by RT-
qPCR. The expression of IFN-λ2 mRNA is plotted relative to vector-transfected cells, after 
normalization to 18S rRNA.
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(C–E) NUDT21 and CPSF6 were knocked down by siRNA in A549 cells, using a mixture of 
2 siRNAs. Cells were then infected with WT PR8 IAV for 15 h. Infection rates were 
assessed by staining for IAV proteins and host shutoff by staining for nuclear PABP.
(C) Representative immunofluorescence images. Scale bar, 200 μm, indicated as an arrow in 
the lower left corner.
(D and E) change in the fraction of infected cells with nuclear PABP (D) or total cell counts 
and infected cells (E), relative to control siRNA. Bars are means ± SDs; n ≥ 3. *p < 0.05 and 
***p < 0.001. ANOVA followed by Dunnett’s multiple comparison test versus control 
siRNA. See also Figure S6.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
CPSF6 (clone F-3) Santa Cruz Biotechnology Cat#sc-376228; RRID: AB_10992032
NUDT21 (clone 2203C3) Santa Cruz Biotechnology Cat#sc-81109; RRID: AB_2153989
PABPC1 (clone 10E10) Santa Cruz Biotechnology Cat#sc-32318; RRID: AB_628097
Tubulin (clone H-235) Santa Cruz Biotechnology Cat#sc-9104; RRID: AB_2241191
Myctag (clone 9B11) Cell Signaling Technologies Cat#2276; RRID: AB_331783
Nucleophosmin Cell Signaling Technologies Cat#3542; RRID: AB_2155178
Influenza A virus Abeam Cat#ab20841; RRID: AB_775660
Nucleolin Abeam Cat#ab22758; RRID: AB_776878
Firefly luciferase Abeam Cat#ab21176; RRID: AB_446076
IFNL2/IL-28A Abeam Cat#ab109820; RRID: AB_10859066
PUF60 Bethyl Laboratories Cat#A302-817A; RRID: ABJ0631036
RBM39 Atlas Cat#HPA001591; RRID: AB_1079749
Anti-mouse secondary coupled to horseradish peroxidase Southern Biotech Cat#103005; RRID: AB_2619742
Anti-rabbit secondary coupled to horseradish peroxidase Southern Biotech Cat#403005; RRID: AB_2687483
Anti-goat secondary coupled to horseradish peroxidase Southern Biotech Cat#616005
Anti-goat secondary coupled to Alexa Fluor-488 Thermo Fisher Cat # A-11055; RRID: AB_2534102
Anti-mouse secondary coupled to Alexa Fluor-555 Thermo Fisher Cat # A-31570; RRID: AB_2536180
Bacterial and Virus Strains
Influenza A virus A/Puerto Rico/8/34 H1N1 Khaperskyy et al., 2012 PR8
Influenza A virus A/Puerto Rico/8/34 H1N1 PA(fs) Khaperskyy et al., 2016 PR8 PA(fs)
Influenza A virus A/Puerto Rico/8/34 H1N1 PA(X9) This paper PR8 PA(X9)
Influenza A virus A/Puerto Rico/8/34 H1N1 PA(AX) This paper PR8 PA(ΔX)
Chemicals, Peptides, and Recombinant Proteins
Streptavidin conjugated to Alexa Fluor-488 Life Technologies / Thermo Fisher / Molecular Probes Cat # S32354; RRID: AB_2315383
Streptavidin conjugated to horseradish peroxidase Cell Signaling Technologies Cat # 3999; RRID:AB_10830897
Lipofectamine RNAiMAX transfection reagent Life Technologies / Thermo Fisher Cat # 13778150
Trizol Life Technologies / Thermo Fisher Cat # 15596018
Turbo DNase Life Technologies / Thermo Fisher Cat # AM2239
RNase A QIAGEN Cat # 19101
HiFi assembly mix New England Biolabs E5520S
polyethylenimine VWR Cat # 87001–912
Doxycycline Fisher BP26531
MycTrap magnetic agarose beads ChromoTek Cat# ymta-20; RRID: AB_2631370
Control magnetic agarose beads ChromoTek Cat# bmab-20
complete protease inhibitors Roche Cat# 11873580001
Total protein stain for Li-Cor LI-COR biosciences P/N926–11010
Critical Commercial Assays
iScript Reverse Transcription Supermix for RT-qPCR Bio-Rad 170–8841
Cell Rep. Author manuscript; available in PMC 2019 May 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Gaucherand et al. Page 41
REAGENT or RESOURCE SOURCE IDENTIFIER
Quick-RNA miniprep kit Zymo Research R1050
iTaq Universal SYBR® Green Supermix Bio-Rad 172–5125
RNeasy Plus minikit QIAGEN 74134
ERCC ExFold RNA spike-in mix Life Technologies / Thermo Fisher 4456739
TruSeq Stranded Total RNA Library Prep Kit with Ribo-
Zero Human Illumina RS-122–2301
High Capacity Neutravidin Agarose Beads Thermo Fisher Cat # 29200
Pierce Trypsin protease, MS-Grade Thermo Fisher Cat # 90057
Deposited Data
Raw sequencing data and fold changes This paper, GEO (NCBI) GEO:GSE120183
Experimental Models: Cell Lines
Human epithelial kidney cells HEK293A Thermo Fisher Cat # R70507
Human epithelial kidney cells HEK293T ATCC ATCCCRL-3216
Human adenocarcinoma alveolar basal epithelial cells 
A549 ATCC ATCCCCL-185
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible PR8 PA-X wt line #1 Khaperskyy et al., 2016 A549 iPA-X wt #1
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible PR8 PA-X wt line #10 Khaperskyy et al., 2016 A549iPA-X wt #10
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible PR8 PA-X D108A line #2 Khaperskyy et al., 2016 A549iPA-XD108A #2
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible PR8 PA-X D108A line #8 Khaperskyy et al., 2016 A549iPA-XD108A #8
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible Udorn PA-X wt line #18 This paper A549 iPA-X Udorn
Human adenocarcinoma alveolar basal epithelial cells 
A549 - inducible PR8 PA-X N terminus (aa 1–191) line 
#8
This paper A549 iPA-X Nterm
Human epithelial kidney cells HEK293T inducible PR8 
PA-X wt line #T7 Khaperskyy et al., 2016 293T iPA-X wt
Oligonucleotides
Control Stealth siRNA Life Technologies / Thermo Fisher Cat #12935300
NUDT21 Stealth siRNA (#1) Life Technologies / Thermo Fisher Cat # 1299001 - HSS117100
NUDT21 Stealth siRNA (#2) (used for Figure 7B) Life Technologies / Thermo Fisher Cat #1299001 - HSS117102
CPSF6 Stealth siRNA (#1) Life Technologies / Thermo Fisher Cat #1299001 - HSS117104
CPSF6 Stealth siRNA (#2) Life Technologies / Thermo Fisher Cat # 1299001 - HSS117103
Nucleolin Stealth siRNA Life Technologies / Thermo Fisher Cat # 1299001 - HSS106985
Nucleolin Stealth siRNA Life Technologies / Thermo Fisher Cat # 1299001 - HSS106984
RBM39 Stealth siRNA Life Technologies / Thermo Fisher Cat #1299001 - HSS145210
RBM39 Stealth siRNA Life Technologies / Thermo Fisher Cat # 1299001 - HSS145212
Primers for qPCR and splicing assays This paper See Table S3
Recombinant DNA
pCR3.1-PA-X_PR8-myc Khaperskyy et al., 2014 N/A
pCR3.1-PA-X_TN/CA/7-myc Khaperskyy et al., 2016 N/A
pCR3.1-PA-N191_PR8-myc Khaperskyy et al., 2016 N/A
pCR3.1-PA-X_Udorn-myc This paper N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
pCR3.1-PA-X_15aa_PR8-myc This paper N/A
pCR3.1-PA-X_9aa_PR8-myc This paper N/A
pTRIPZ_PA-X-Nterm (aa 1–191)_ PR8-myc This paper N/A
pTRIPZ_PA-X_Udom-myc This paper N/A
pCMV-IFNL2 cDNA This paper N/A
pCMV-IFNL2 genomic This paper N/A
pCMV-IFNL2 intron 1 only This paper N/A
pCMV-IFNL2 intron 2 only This paper N/A
pCMV-IFNL2 intron 3 only This paper N/A
pCMV-IFNL2 intron 4 only This paper N/A
pCMV-IFNL2 intron 5 only This paper N/A
pCMV-IFNL2 mutated intron 2 only This paper N/A
pCMV-IFNL2 mutated intron 4 only This paper N/A
pcDNA3.1-myc-BiolD2-MCS Roux et al., 2012 Addgene # 74223
pCR3.1-BirA*-myc This paper N/A
pCR3.1-BirA*-X61-myc This paper N/A
pCR3.1-BirA*-X61 (4A)-myc This paper N/A
pCR3.1-BirA*-X41(CA/7) This paper N/A
CMV-LUC2CP/intron/ARE Gift from Gideon Dreyfuss; Younis et 
al., 2010 N/A
CMV-LUC2CP/ARE Gift from Gideon Dreyfuss; Younis et 
al., 2010 N/A
pCDNA3.1-p-globin Covarrubias et al., 2011 N/A
Software and Algorithms
Prism 7 GraphPad N/A
Tophat Kim et al., 2013, https://ccb.jhu.edu/
software/tophat/index.shtml V2.1.1
Cufflinks Trapnell et al., 2012, http://cole-trapnell-lab.github.io/cufflinks/ V2.2.1
GeneSys (chemiblot imager) Syngene V1.5.4.0
Image Studio 5.2 (LI-COR imager) LI-COR biosciences V5.2
CFX Manager 3.1 program Bio-Rad N/A
STRING program https://string-db.org/, Szklarczyk et al., 2017 V10.5
Cluster3.0 bonsai.hgc.jp/~mdehoon/software/cluster/software.htmN/A
MaxEntScan::score5ss Yeo and Burge, 2004 N/A
http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html
DAVID Gene Ontology
Huang et al., 2009a, 2009b,
V6.8
https://david.ncifcrf.gov
Other
Human genome sequence and annotation (.fasta, .gtf) UCSC https://ccb.jhu.edu/software/tophat/igenomes.shtmlhg19
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